Table 1 Mortality rate determination of CrmD recombinant ECTVs in susceptible BALB/c mice

From: Chemokines cooperate with TNF to provide protective anti-viral immunity and to enhance inflammation

Dose (pfu)

ECTV

ECTV RevCrmD

ECTV ∆CrmD

ECTV RevCRD

 

Survivors

MTD

Survivors

MTD

Survivors

MTD

Survivors

MTD

10

4/10

10.0 (9–11)

0/10

11.6 (9–21)

10/10

n.a.

10/10

n.a.

10e2

0/5

11.8 (9–18)

1/5

12.8 (10–11)

5/5

n.a.

5/5

n.a.

10e3

0/5

10.4 (9–14)

0/5

10.2 (9–13)

5/5

n.a.

4/5

10

10e4

n.d.

n.d.

0/5

8.6 (8–10)

5/5

n.a.

5/5

n.a.

10e5

n.d.

n.d.

0/5

9.6 (8–13)

5/5

n.a.

3/5

9 (8–10)

10e6

n.d.

n.d.

n.d.

n.d.

5/5

n.a.

n.d.

n.d.

10e7

n.d.

n.d.

n.d.

n.d.

4/5

14

1/5

12.5 (10–16)

  1. Groups of 5 or 10 BALB/c female mice were infected s.c. in the left hind footpad with different doses of the indicated viruses. The number of survivors at 32 dpi and the mean time to death (MTD) and survival range (in parenthesis) in days for each condition are shown
  2. n.a. not applicable, n.d. not determined